1stOncology™: Cancer Intelligence Service – Page 13054 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Intec Pharma to Participate in September Investment Conferences

On September 3, 2019 Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") reported that Company management will participate at the following upcoming investment conferences in September (Press release, Intech Pharmaceuticals, SEP 3, 2019, https://www.prnewswire.com/news-releases/intec-pharma-to-participate-in-september-investment-conferences-300910451.html [SID1234539225]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

HC Wainwright 21st Annual Global Investment Conference
Date: September 8-10, 2019
Company Presentation: Monday, September 9, 2019 at 4:40 pm (Eastern time)

Location: Lotte New York Palace Hotel, New York City
Presenter: Jeffrey A. Meckler, Vice Chairman and Chief Executive Officer of Intec Pharma
Format: Corporate presentation and One-on-One Investor Meetings

Ladenburg Thalmann 2019 Healthcare Conference
Date: September 24, 2019

Company Presentation: September 24, 2019 at 11:30 am (Eastern time)
Location: Sofitel, New York City
Presenter: Walt Linscott, Chief Business Officer
Format: Corporate presentation and One-on-One Investor Meetings

Both presentations will be webcast live and will be accessible through the Events section of Intec Pharma’s website at www.intecpharma.com, where they will also be archived for a period of time.

CASI Pharmaceuticals, Inc. To Present At The 2019 H.C. Wainwright 21st Annual Global Investment Conference

On September 3, 2019 CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China, U.S., and throughout the world, reported it will present at the 2019 H.C. Wainwright 21st Annual Global Investment Conference being held September 8-10, 2019 in New York, NY (Press release, CASI Pharmaceuticals, SEP 3, 2019, https://www.prnewswire.com/news-releases/casi-pharmaceuticals-inc-to-present-at-the-2019-hc-wainwright-21st-annual-global-investment-conference-300909977.html [SID1234539224]).

Event: H.C. Wainwright 21st Annual Global Investment Conference
Date: Monday, September 9th
Time: 11:40 AM – 12:05 PM
Presenter: Dr. Wei-Wu He
Presentation Room: Holmes II (4th floor) Lotte New York Palace Hotel

A link to the presentation’s webcast as well as a copy of the of the presentation can found on the Company’s website www.casipharmaceuticals.com, on September 9, 2019.

ProMIS Neurosciences to Present at HC Wainwright Investment Conference

On September 3, 2019 ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, reported its participation in the 21st Annual Global Investment Conference sponsored by H.C. Wainwright & Co. LLC (Press release, ProMIS Neurosciences, SEP 3, 2019, https://www.prnewswire.com/news-releases/promis-neurosciences-to-present-at-hc-wainwright-investment-conference-300909802.html [SID1234539223]). The conference is being held September 8-10, 2019 at the New York Palace Hotel in New York.

ProMIS’ Executive Chairman, Eugene Williams will provide overviews of its novel drug discovery and development programs for Alzheimer’s disease, Parkinson’s disease and ALS (amyotrophic lateral sclerosis) Tuesday, September 10th at 10:25 am ET. The audio webcast and slides of Mr. Williams’ presentation will be archived and available on ProMIS’ web site and through the following link View Source

Insmed to Present at Two September Conferences

On September 3, 2019 Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, reported that management will present at the following investor conferences (Press release, Insmed, SEP 3, 2019, View Source [SID1234539222]):

The H.C. Wainwright 21st Annual Global Investment Conference in New York, NY on Tuesday, September 10, 2019 at 8:20 a.m. ET.
The Morgan Stanley 17th Annual Global Healthcare Conference in New York, NY on Tuesday, September 10, 2019 at 5:15 p.m. ET.
The presentations will be webcast live and can be accessed by visiting the investor relations section of the company’s website at www.insmed.com. The webcasts will be archived for a period of 90 days following the conclusion of each live event.

Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

On September 3, 2019 Luminex Corporation (NASDAQ: LMNX) reported that Homi Shamir, President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Morgan Stanley 17th Annual Global Healthcare Conference to be held September 9-11, 2019, in New York, NY (Press release, Luminex, SEP 3, 2019, View Source [SID1234539221]).

The fireside chat will begin at 2:05 p.m. Eastern Time on Tuesday, September 10, 2019.

The presentation will be webcast live and may be accessed at Luminex Corporation’s website at www.luminexcorp.com. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. The presentation will be archived for six months on the website using the ‘replay’ link.